Prostate cancer cases spike in this US state as doctors share likely reason
A new study by UC San Francisco found that prostate cancer cases are increasing in California, likely due to a change in ...
Aggressive prostate cancer on rise in California, climbing faster than US average, says study
A new UCSF study shows a significant increase in advanced prostate cancer cases in California, growing faster than the ...
LAist on MSN23h
Aggressive prostate cancer is surging in California. What you need to know
Advanced prostate cancer cases are rising sharply in California, outpacing national trends, according to a new study from ...
California sees an ‘alarming’ rise in advanced prostate cancer, UCSF study finds
A new study from UCSF reveals an “alarming” rise in advanced prostate cancer rates across California. The findings, published ...
Health Rounds: Vaccine keeps advanced kidney cancer from recurring
Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...
Science Daily4d
Alarming rise in rates of advanced prostate cancer in California
The incidence of advanced prostate cancer in California rose markedly in the decade since doctors stopped routinely screening all men for the disease, according to a new study.
California sees alarming rise in rates of advanced prostate cancer since routine screening stopped
The incidence of advanced prostate cancer in California rose markedly in the decade since doctors stopped routinely screening ...
devdiscourse15h
Breakthrough Trials in Cancer and Vision Treatments
Recent scientific studies have shown promising advancements in medical treatments. A personalized vaccine significantly ...
RedHill Announces Initiation of Phase 2 Study of Opaganib and Darolutamide in Advanced Prostate Cancer
RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced ...
RedHill Biopharma Launches Phase 2 Trial For Advanced Prostate Cancer Treatment
(RTTNews) - RedHill Biopharma (RDHL) Tuesday announced that it has launched a Phase 2 trial to assess opaganib's ability to enhance darolutamide in treating metastatic castrate-resistant prostate ...
Cortechs.ai and EDAP Announce World’s First OnQ™ Prostate-Assisted Focal One® Robotic HIFU Procedure at UCSF Prostate Cancer Center
First Focal One® procedure utilizing Cortechs.ai’s advanced MRI-imaging technology, OnQ Prostate, successfully performed at the University of ...